# EDGAR Filing Document

**Accession Number:** 0001979414
**File Stem:** 0000000000-26-003785
**Filing Date:** 2026-4
**Character Count:** 2248
**Document Hash:** f2fc625bd694ad5e4e0d02b6ea59d095
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003785.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0000000000-26-003785

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260414

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEONC TECHNOLOGIES HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001979414
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 921954864
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294999

**BUSINESS ADDRESS:**
- **STREET 1:** 23975 PARK SORRENTO
- **STREET 2:** SUITE 205
- **CITY:** CALABASAS
- **STATE:** CA
- **ZIP:** 91302
- **BUSINESS PHONE:** 310 663 7831

**MAIL ADDRESS:**
- **STREET 1:** 23975 PARK SORRENTO
- **STREET 2:** SUITE 205
- **CITY:** CALABASAS
- **STATE:** CA
- **ZIP:** 91302
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001829126-26-003412

## Text-Extract

```

                                                           April 14, 2026

Amir Heshmatpour
Chief Executive Officer and President
NeOnc Technologies Holdings, Inc.
23975 Park Sorrento, Suite 205
Calabasas, CA 91302

       Re: NeOnc Technologies Holdings, Inc.
           Registration Statement on Form S-3
           Filed April 10, 2026
           File No. 333-294999
Dear Amir Heshmatpour:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Chris Edwards at 202-551-6761 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Thomas J. Poletti, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._